Evolution of retroperitoneal lymphadenectomy (RPLND) in the management of non-seminomatous testicular cancer (NSGCT)

Urologic Oncology: Seminars and Original Investigations

Volumn 21, Issue 2, 2003, Pages 129-132

  Donohue, John P ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

History evolution; Retroperitoneal lymphadenectomy (for testis cancer)

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM DERIVATIVE;

CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; HUMAN; LYMPHADENECTOMY; PRIORITY JOURNAL; RETROPERITONEUM; REVIEW; SURGICAL APPROACH; TESTIS CANCER; TREATMENT FAILURE; ARTICLE; HISTORY; MALE; METHODOLOGY; TESTIS TUMOR;

HISTORY, 20TH CENTURY; HUMANS; LYMPH NODE EXCISION; MALE; NEOPLASM STAGING; RETROPERITONEAL SPACE; TESTICULAR NEOPLASMS;

EID: 0041884997     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-1439(02)00212-0     Document Type: Article

References (43)

1. Kober GM. Teratoma testis, 114 Cases. Am J Med Sci 1899;CX-VII:535.
2. Stimson JC. A new operation for teratoma testis. Med Rec NY 1897;III:623.
3. Most. Uber die lymphgefässe und lymphdrüssen des hodens. Arch. f. Anat. u. Entweckingsgesh: 1899; 113.
4. Cuneo B. Note sur les lymphatiques du testicule. Bull. et Mem. Soc. Anat. de Paris, 1901;76:105.
5. Jamison JK, Dobson JF. The lymphatics of the testicle. Lancet, London 1910;493: Feb. 19.
6. Chevassu M. Deux cas d'epitheliome du testicule traite par castration et l'ablation des ganglions lumboaortique. Bull. et Mem. Soc. de Chir. Paris 1910;36:236.
7. Villar F. Methode rationelle pour practiquer la castration das cas de tumeurs du testicule. Ann. Soc. de med du Gard 1902;i:183.
8. Roberts D. Elective transperitoneal RPLND. Ann Surg 1901;36:539.
9. Hinman F. The operative treatment of tumors of the testicle. JAMA 1914;58:2009.
10. Hinman F. The radical operation for teratoma testis. SGO 1919;28:495.
11. Lewis L. Management of testicular cancers at Walter Reed Army Hospital. J Urol 1948;59:763.
12. Patton JF, Hewitt CB, Mallis N. Diagnosis and treatment of tumors of the testis. JAMA 1959;116:2194.
13. Van Burskirk KE, Young JG. Retroperitoneal lymphadenectomy for testis cancer. Military Med. 1959;133:575.
14. Stanbitz WJ, Magoos I. Transabdominal retroperitoneal lymphadenectomy in the management of non seminomatous testicular cancer. J Urol 1973;100:350.
15. Whitmore WF. Retroperitoneal lymphadenectomy for testicular cancer. Contemp Surg 1975;6:17.
16. Cooper JF, Leadbetter WF, Chute R. The thoracoabdominal approach for retroperitoneal gland dissection: its application to testis tumors. Surg Gynecol Obstet 1950;90:486.
17. Skinner GD. Surgical management of advanced non seminomatous germinal tumors of the testis. Urol. Clin. No. Am. 1977;4:465.
18. Fraley EE, Markland C, Lange PH. Surgical treatment of stage I and II nonseminomatous testicular cancer in adults. Urol. Clin. No. Am. 1977;4:453.
19. Richie JP. Clinical stage I testicular cancer: the role of modified retroperitoneal lymphadenectomy. J Urol 1990;144:1160.
20. Chiappa S, Uslenghi C, Bonadonna G, et al. Combined testicular and foot lymphangiography in testicular carcinomas. Surg Gynecol Obstet 1966;123:10.
21. Sayegh ES, Busch FM. Roentgenographic visualization of human testicular lymphatics: a preliminary report. J Urol 1963;89:106.
22. Wahlquist L, Hutten L, Rosenkrantz M. Normal lymphatic drainage of the testis studied by funicular lymphography. Acta Chir Scand 1966;132:454.
23. Ray B, Hajdu SI, Whitmore WF Jr. Distribution of retroperitoneal lymph node metastases in testicular germinal tumors. Cancer 1974;33:340.
24. Donohue JP, Zachary JM, Maynard SM. Distribution of nodal metastases in non-seminomatous testicular cancer. J Urol 1982;128:315.
25. Weisbach L, Boedefeld E. Localization of solitary and multiple metastasis in stage II non seminomatous testis tumors as a basis for a modified staging lymph node dissection in stage I. J Urol 1982;138:77.
26. Walsh P, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982;128:492.
27. Walsh P, Lepor H, Eggleston JC. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 1983;4:473.
28. Narayan P, Lange P, Fraley EE. Ejaculation and fertility after extended retro-peritoneal lymph node dissection for testicular cancer. World J Urol 1982;127:685.
29. Pizzocaro G, Salvioni R, Zononi F. Unilateral lymphadenectomy in intraoperative stage I NSGCT. J Urol 1985;134:485.
30. Richie JP. Modified retroperitoneal lymphadenectomy for patients with clinical stage I testicular cancer. Semin Urol 1986;6:216.
31. Jewett MA, Kong Y, Goldberg J, et al. Retroperitoneal lymphadenectomy for testicular tumor with preservation of ejaculation. J Urol 1988;139:1220.
32. Colleselli K, Poisel S, Schachtner W, et al. Nerve sparing bilateral retroperitoneal lymphadenectomy anatomical study and operative approach. J Urol 1990;144:293.
33. Donohue JP, Foster RS, Geier G, et al. Preservation of ejaculation following nerve sparing RPLND. J Urol 1988;139:206.
34. Donohue JP, Foster RS, Geier G, et al. Preservation of ejaculation following nerve sparing RPLND. Ibid. J Urol 1990;144:293.
35. Einhorn L, Donohue JP. Cis-diamminedichloroplatinum, vinblastine and bleomycin chemotherapy in disseminated testicular cancer. Ann. Int. Med. 1977;87:293.
36. Donohue JP, Einhorn LH, Williams SD. Cytoreductive surgery for metastatic testis cancer: considerations of timing and extent. J Urol 1980;123:876.
37. Donohue JP, Rowland RG. The role of surgery in advanced testicular cancer. Cancer 1984;54:2716.
38. Donohue JP. Retroperitoneal lymphadenectomy: the anterior approach including bilateral and suprarenal hilar dissection. Urol Clin No Am. 1977;4:509.
39. Murphy BR, Breeden ES, Donohue JP, et al. Surgical salvage of chemorefractory germ cell tumors. J Clin Oncol 1993;11:324.
40. Donohue JP, Thornhill JA, Foster RS, Bihrle R. Vascular considerations in post chemotherapy RPLND. Part I-vena cava: part II-aorta. World J Urol 1994;12:182-9.
41. Nash PA, Liebovitch I, Foster RS, et al. En bloc nephrectomy in patients undergoing post chemotherapy RPLND for advanced NSGCT: indications, implications and outcomes. J Urol 1998;159:707.
42. Foster RS, Bihrle R, Sanghvi NT, Fry FJ, Donohue JP. High intensity focused ultrasound in treatment of prostatic disease. Eur J Urol 1993;23:29.
43. Donohue JP, Liebovitch I, Foster RS, Baniel J, Tognoni P. Integration of surgery and systemic therapy: results and principles of integration. Sem. Urol. Oncol. May Vol. 16, No. 2:65-71.